Alpha Tau Medical 

$13.55
119
+$1.67+14.06% Friday 20:00
+$0.14+1.03%Friday 23:59After hours

Statistics

Day High
13.56
Day Low
13.52
52W High
14.11
52W Low
2.87
Volume
5,630
Avg. Volume
-
Mkt Cap
1.22B
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

18AugExpected
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Next
-0.26
-0.21
-0.15
-0.1
Expected EPS
-0.140878
Actual EPS
N/A

Financials

-Profit Margin
Unprofitable
2021
2022
2023
2024
2025
0Revenue
-42.63MNet Income

Analyst Ratings

12.60Average Price Target
The highest estimate is 17.00.
From 5 ratings within the last 6 months. This is not an investment recommendation.
Buy
80%
Hold
20%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow DRTS. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Acadia Pharmaceuticals
ACAD
Mkt Cap4.49B
Accuray Incorporated designs and manufactures radiation oncology systems, offering similar cancer treatment solutions.
Intuitive Surgical
ISRG
Mkt Cap144.07B
Intuitive Surgical provides robotic surgical systems, which are used in minimally invasive surgeries, including cancer-related procedures.
Zimmer Biomet
ZBH
Mkt Cap17.67B
Zimmer Biomet Holdings, Inc. focuses on orthopedic and medical devices but competes in the broader medical technology market for cancer treatments.
Medtronic
MDT
Mkt Cap107.36B
Medtronic plc offers various healthcare solutions, including technologies and therapies for treating cancer, overlapping with Alpha Tau's market.
Stryker
SYK
Mkt Cap126.42B
Stryker Corporation manufactures medical technologies, including surgical equipment and neurotechnology products that can be used in cancer treatments.
Boston Scientific
BSX
Mkt Cap66.54B
Boston Scientific Corporation develops medical devices used in interventional medical specialties, competing in the oncology space.
Baxter International
BAX
Mkt Cap11.68B
Baxter International Inc. provides a range of hospital and renal products, including technologies applicable in cancer treatment settings.
Abbott Laboratories
ABT
Mkt Cap163.61B
Abbott Laboratories offers medical devices, diagnostics, and nutritional products that serve various healthcare needs including oncology.
Johnson & Johnson
JNJ
Mkt Cap618.61B
Johnson & Johnson engages in the research and development, manufacture, and sale of a broad range of healthcare products, indirectly competing in the oncology sector.

About

Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer. Its Alpha-DaRT technology is in clinical trials for various forms comprising skin, oral, pancreatic, prostate, lung, liver, and breast cancers; and preclinical clinical studies for mouse tumors and human-derived tumors. The company is headquartered in Jerusalem, Israel.
Show more...
CEO
Mr. Uzi Sofer
Employees
118
Country
Israel
ISIN
IL0011839383

Listings

0 Comments

Share your thoughts

FAQ

What is Alpha Tau Medical stock price today?
The current price of DRTS is $13.55 USD — it has increased by +14.06% in the past 24 hours. Watch Alpha Tau Medical stock price performance more closely on the chart.
What is Alpha Tau Medical stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Alpha Tau Medical stocks are traded under the ticker DRTS.
Is Alpha Tau Medical stock price growing?
DRTS stock has risen by +6.61% compared to the previous week, the month change is a +38.55% rise, over the last year Alpha Tau Medical has showed a +345.72% increase.
What is Alpha Tau Medical market cap?
Today Alpha Tau Medical has the market capitalization of 1.22B
When is the next Alpha Tau Medical earnings date?
Alpha Tau Medical is going to release the next earnings report on August 18, 2026.
What were Alpha Tau Medical earnings last quarter?
DRTS earnings for the last quarter are -0.26 USD per share, whereas the estimation was -0.12 USD resulting in a -110.43% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Alpha Tau Medical revenue for the last year?
Alpha Tau Medical revenue for the last year amounts to 0 USD.
What is Alpha Tau Medical net income for the last year?
DRTS net income for the last year is -42.63M USD.
How many employees does Alpha Tau Medical have?
As of July 18, 2026, the company has 118 employees.
In which sector is Alpha Tau Medical located?
Alpha Tau Medical operates in the Health & Wellness sector.
When did Alpha Tau Medical complete a stock split?
Alpha Tau Medical has not had any recent stock splits.
Where is Alpha Tau Medical headquartered?
Alpha Tau Medical is headquartered in Jerusalem, Israel.